SKY-1214

N/A

Report date: 2024/07/11 14:38:37
NME

Base Information

Drug NameSKY-1214
Drug Alias NameSKY-1214
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA splicing modulatorsFANCD2 And FANCI Associated Nuclease 1 modulators
TargetsFANCD2 And FANCI Associated Nuclease 1
Therapy Area/IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSkyhawk Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSkyhawk Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A